Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins

Christie, Michael R., Roll, Ursula, Payton, Mark A. , Hatfield, Emma C. I. and Ziegler, Annette- G. (1997) Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care, 20 (6). pp. 965-970. ISSN 0149-5992

Full text not available from this repository.

Item Type:Article
Item Status:Live Archive

Abstract

OBJECTIVE - To determine whether screening for the presence of multiple antibody markers for IDDM is effective at identifying individuals with high risk for disease development. RESEARCH DESIGN AND METHODS - Antibodies to GAD and the tyrosine phosphatase-like protein IA-2 were determined in sequential serum samples from 44 first-degree relatives of IDDM patients, identified as possessing islet cell antibody (ICA) and/or insulin autoantibody (IAA), who were followed prospectively for IDDM development. ICA, IAA, and antibodies to GAD and IA-2 were also determined in 93 cases of new-onset nonfamilial IDDM. RESULTS - The presence of two or more antibodies in addition to ICA or IAA conferred high risk (61%) for development of IDDM within 5 years of entry into the study and identified 89% of those who have developed IDDM on current follow-up. None of the relatives positive for ICA or IAA alone, in the absence of other antibody markers, have developed IDDM. Antibodies to islet antigens could both appear and disappear in follow-up samples obtained after entry into the study. The majority (60%) of young (< 16 years), sporadic cases of IDDM had multiple antibodies to islet antigens, but this proportion was lower in older patients (37%). CONCLUSIONS - A screening strategy based on die analysis of antibodies to multiple islet antigens can predict IDDM at high sensitivity and specificity in families, and such a strategy may also be applicable to identify young individuals in the general population with high disease risk. Since appearance of antibodies to different antigens occurs sequentially rather than simultaneously, accurate assessment of diabetes risk based on the presence of multiple antibodies will require follow-up over a number of years after the first evidence islet autoimmunity.

Keywords:autoantibody, glutamate decarboxylase, insulin antibody, pancreas islet cell antibody, protein antibody, protein tyrosine phosphatase, adolescent, adult, antibody detection, article, autoimmunity, child, diagnostic value, female, high risk patient, human, infant, insulin dependent diabetes mellitus, major clinical study, male, relative, Adolescent, Autoantibodies, Autoantigens, Child, Preschool, Diabetes Mellitus, Type 1, Follow-Up Studies, Humans, Insulin Antibodies, Islets of Langerhans, Life Tables, Mass Screening, Membrane Proteins, Nuclear Family, Protein-Tyrosine-Phosphatase, Reproducibility of Results, Risk Assessment, Risk Factors, Time Factors
Subjects:A Medicine and Dentistry > A100 Pre-clinical Medicine
Divisions:College of Science > School of Life Sciences
Related URLs:
ID Code:18148
Deposited On:07 Aug 2015 10:17

Repository Staff Only: item control page